Genome-Wide CRISPR Screen Reveals Autophagy Disruption as the Convergence Mechanism That Regulates the NRF2 Transcription Factor
Related Experiment Video
Updated: Jan 26, 2026

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes
Published on: May 23, 2025
Michael J Kerins1, Pengfei Liu1, Wang Tian1
1Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, Arizona, USA.
Abstract:
The nuclear factor (erythroid 2)-like 2 (NRF2 or NFE2L2) transcription factor regulates the expression of many genes that are critical in maintaining cellular homeostasis. Its deregulation has been implicated in many diseases, including cancer and metabolic and neurodegenerative diseases. While several mechanisms by which NRF2 can be activated have gradually been identified over time, a more complete regulatory network of NRF2 is still lacking. Here we show through a genome-wide clustered regularly interspaced short palindromic repeat (CRISPR) screen that a total of 273 genes, when knocked out, will lead to sustained NRF2 activation. Pathway analysis revealed a significant overrepresentation of genes (18 of the 273 genes) involved in autophagy. Molecular validation of a subset of the enriched genes identified 8 high-confidence genes that negatively regulate NRF2 activity irrespective of cell type: ATG12, ATG7, GOSR1, IFT172, NRXN2, RAB6A, VPS37A, and the well-known negative regulator of NRF2, KEAP1 Of these, ATG12, ATG7, KEAP1, and VPS37A are known to be involved in autophagic processes. Our results present a comprehensive list of NRF2 negative regulators and reveal an intimate link between autophagy and NRF2 regulation.
Insights
A genome-wide screen identified 273 genes that activate nuclear factor (erythroid 2)-like 2 (NRF2). Eight high-confidence NRF2 negative regulators, including several involved in autophagy, were validated, revealing a link between autophagy and NRF2.
Area of Science:
- Cellular Biology
- Molecular Biology
- Genetics
Background:
- Nuclear factor (erythroid 2)-like 2 (NRF2) is a transcription factor crucial for cellular homeostasis.
- NRF2 deregulation is linked to diseases like cancer and neurodegeneration.
- A complete regulatory network for NRF2 remains elusive.
Purpose of the Study:
- To identify novel regulators of NRF2.
- To elucidate the relationship between NRF2 and other cellular processes.
Main Methods:
- Genome-wide CRISPR screen to identify NRF2 activators.
- Pathway analysis to identify enriched biological processes.
- Molecular validation of candidate NRF2 regulators.
Main Results:
- A CRISPR screen identified 273 genes whose knockout leads to sustained NRF2 activation.
- Pathway analysis revealed autophagy-related genes are significantly overrepresented.
- Eight high-confidence NRF2 negative regulators were validated, including ATG12, ATG7, KEAP1, and VPS37A, which are involved in autophagy.
Conclusions:
- This study presents a comprehensive list of NRF2 negative regulators.
- An intimate link between autophagy and NRF2 regulation is revealed.
Related Concept Videos
Transcription Factors
Transcription Elongation Factors
The transcription elongation is regulated via pausing of RNA polymerase on several occasions during transcription. In bacteria, these halts are necessary because the transcription of DNA into mRNA is coupled to the translation of that mRNA...
Master Transcription Regulators
Master Transcription Regulators
Cooperative Binding of Transcription Regulators
CRISPR

